Global RNA Sequencing Market 2016 to 2022: Market to Grow at a CAGR of 12.07% to Reach $3.6 Billion, from $1.86 Billion in 2016

The global RNA sequencing (RNA-Seq) market is projected to witness a significant growth rate during the forecast period, growing at a CAGR of 12.07% during the forecast period to reach a total market size of US$3.692 billion by 2022, increasing from US$1.863 billion in 2016.

The global RNA sequencing (RNA-Seq) market is projected to witness a significant growth rate during the forecast period, growing at a CAGR of 12.07% during the forecast period to reach a total market size of US$3.692 billion by 2022, increasing from US$1.863 billion in 2016.

Viral evolution and increasing incidence of genetic disorders have elevated the need for technical advancements in RNA sequencing products which are expected to drive the market over the projected period. Increasing grants for RNA sequencing have led to increasing number of research activities involving RNA sequencing. However, lack of skilled professionals required for RNA sequencing will impede the market growth. Moreover, strict government regulations in some regions will further slow down the growth rate of the market.

The major players discussed in this report include Illumina, Inc., Macrogen Inc., GATC Biotech AG., Eurofins Scientific, PerkinElmer Inc., and Oxford Nanopore Technologies among few others.

Segmentation

By Technology

By Applications

By End-User

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/7p87h5/global_rna?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716